Table 3.

Adjusted Hazard Ratios^* for overall mortality or cardiovascular events among liver transplant recipients with BP controlled vs. those with uncontrolled BP during year 1 post-transplant

	Overall Mortality				CVEs^
	Hazards Ratio	95% CI		P value	Hazards Ratio	95% CI		P value
BP controlled < 140/90 mmHg	0.58	0.39	0.87	0.008	0.65	0.43	0.97	0.03
Age (per year)	1.06	1.04	1.08	<.0001	1.001	0.98	1.012	0.95
Female sex	0.95	0.72	1.27	0.74	0.62	0.44	0.87	0.005
Diabetes	0.72	0.55	0.95	0.02	1.29	0.95	1.76	0.10
CKD	1.19	0.83	1.71	0.35	2.03	1.24	3.33	0.005
Hyperlipidemia	0.64	0.48	0.85	0.002	1.38	1.01	1.89	0.05
	Hazards Ratio	95% CI		P value	Hazards Ratio	95% CI		P value
BP controlled < 130/80 mmHg	0.91	0.53	1.55	0.73	0.93	0.52	1.65	0.80
Age (per year)	1.06	1.05	1.08	<.0001	1.002	0.99	1.02	0.80
Female sex	0.95	0.71	1.26	0.71	0.62	0.44	0.86	0.005
Diabetes	0.74	0.56	0.97	0.03	1.32	0.97	1.79	0.08
CKD	1.21	0.84	1.74	0.30	2.09	1.27	3.43	0.004
Hyperlipidemia	0.65	0.49	0.87	0.003	1.40	1.02	1.93	0.04

^*Time-dependent Cox Proportional Hazard Analyses; all comorbidities included as time-varying covariates except sex which was recorded at time of transplant

^{^}CVE defined as death from a CV cause or hospitalization for post-transplant myocardial infarction or revascularization, cardiac arrest, heart failure, atrial fibrillation, thromboembolism, or stroke

Abbreviations: CKD, chronic kidney disease; CVE, cardiovascular events; BP, blood pressure; CI, confidence interval; CKD, chronic kidney disease.